Methods of tissue induction using a combination of bone morphogenetic protein and parathyroid hormone-related peptide
CA 2249212 A1 · Owner: Genetics Institute, Llc · Inventors: Hattersley, Gary; Rosen, Vicki A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions of proteins with chondrocyte and cartilaginous tissue inducing activity, as well as method of using those compositions are disclosed. The , compositions comprise one or more proteins of the transforming growth factor- .beta. (TGF-.beta.) superfamily of proteins particularly bone morphogenetic , proteins (BMPs) in combination with parathyroid hormone-related polypeptide (PTHrP) or an equivalent PTH-like polypeptide. The compositions and methods are useful in the treatment of osteoarthritis cartilage defects and in , related tissue repair.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 17, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 17, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 17, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.